Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Can We Use Just Minoxidil for Alopecia Areata?
Description
This talk discusses the use of minoxidil for treating alopecia areata, addressing whether it can be used as a standalone treatment. Evidence from clinical trials suggests that topical minoxidil can be effective, particularly for patchy alopecia areata, though the quality of this evidence is moderate due to small trial sizes and potential biases. Oral minoxidil has also been studied, with varying response rates from patients, especially those with less severe scalp involvement. Combining oral minoxidil with Janus kinase (JAK) inhibitors has shown promising results in some studies. The Brazilian Society of Dermatology recommends minoxidil for all severities of alopecia areata, and while the preference is often for topical or oral combinations, standalone minoxidil remains a viable option for patients who cannot use other treatments. Concerns about adverse effects, particularly cardiovascular, are addressed, highlighting the safety of low doses and suggesting a gradual dose increase to mitigate risks. Additionally, sublingual minoxidil may reduce the incidence of heart palpitations compared to oral minoxidil. The presentation concludes by affirming that while minoxidil is not the only treatment, it can provide significant benefits for patients, particularly those in need of quicker results.
View moreConclusions
- Topical minoxidil is effective for patchy alopecia areata with a regrowth rate of 73% compared to 8% for placebo.
- The quality of evidence for topical minoxidil's efficacy is moderate due to small sample sizes and some risk of bias in studies.
- Oral minoxidil shows potential benefits for alopecia areata but has historically been underutilized due to low cosmetic response rates.
- Combination treatment of oral minoxidil with JAK inhibitors has shown promising results, achieving better outcomes than JAK inhibitors alone.
- The Brazilian Society of Dermatology recommends minoxidil for all stages of alopecia areata, integrating it as part of a combination treatment strategy.
- Minoxidil may be considered as an adjunct therapy rather than a monotherapy for the majority of patients due to the complexity of the condition.
- Start with lower doses of minoxidil and gradually increase to minimize the risk of side effects, particularly cardiovascular issues.
- Sublingual minoxidil can be considered as an alternative to reduce cardiovascular adverse effects while maintaining efficacy.
- ZAIB1, SUMARA RASHID2, RUKHSANA JABEEN3, AHMED AMIN KHAN FRAZ4. Efficacy of topical 5% Minoxidil Solution in the Treatment of Alopecia Areata. JEADV. DOI: 10.1111/jdv.15545
- Fiedler-Weiss VC, Rumsfield J, Buys CM, West DP, Wendrow A. Evaluation of Oral Minoxidil in the Treatment of Alopecia Areata. Arch Dermatol. 1987 Nov;123:1324-1328.
- Müller Ramos P, Anzai A, Duque-Estrada B, Melo DF, Sternberg F, Santos LDN, Alves LD, Mulinari-Brenner F. Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata. An Bras Dermatol. 2024 Dec.
- Müller Ramos PM, Goren A, Sinclair R, Miot HA. Oral minoxidil bio-activation by hair follicle outer root sheath cell sulfotransferase enzymes predicts clinical efficacy in female pattern hair loss. J Eur Acad Dermatol Venereol. 2020.
- Sanabria B, Miot HA, Sinclair R, Chaves C, Müller Ramos P. Sublingual Minoxidil 5 mg versus Oral Minoxidil 5 mg for male androgenetic alopecia: A double-blind randomized clinical trial. J Eur Acad Dermatol Venereol. 2024 Dec.
- Dlova N, et al. Oral minoxidil in the treatment of frontal fibrosing alopecia. JAAD Case Reports. 2022.